Welcome to our dedicated page for SONENDO news (Ticker: SONX), a resource for investors and traders seeking the latest updates and insights on SONENDO stock.
Sonendo, Inc. (SONX) is a pioneering company in the dental industry, dedicated to improving oral health through advanced technology. As a privately held, venture-backed firm, Sonendo has developed the GentleWave® System, a groundbreaking innovation in root canal therapy. This system employs multisonic ultracleaning™ technology which uses a broad spectrum of acoustic energy to clean root canals more effectively than traditional methods.
The GentleWave® System is designed to reach deep into the lateral canals and microscopic tubules of the root canal system, ensuring the removal of tissue, debris, biofilm, and bacteria. This technology provides a less invasive and more efficient alternative to standard instrumentation, aiming to save teeth and improve patient outcomes.
Sonendo's commitment to innovation is backed by extensive research and development. The company receives support from prominent investors such as CVF, LLC, Dinova Capital, Fjord Ventures, Meritech Capital Partners, NeoMed Management, and Orbimed Advisors LLC.
In addition to their flagship product, Sonendo is continuously exploring new technologies and methodologies to enhance dental care. Their work not only benefits dental practitioners by enhancing the cleaning process but also significantly impacts patients' lives by offering more effective and gentle treatment options.
Sonendo, Inc. (NYSE: SONX), a dental technology leader, will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 13 at 2:55 p.m. ET. An audio webcast of the presentation will be accessible via the company’s website. Sonendo is known for its GentleWave® System, which treats tooth decay using innovative technology that preserves tooth structure while enhancing clinical outcomes.
The GentleWave System improves cleaning efficacy, healing rates, and minimizes post-operative pain, thus optimizing workflow for dental practices.
Sonendo reported a strong Q2 2022, achieving $10.5 million in total revenue, a 32% increase from the previous year. The GentleWave console revenue rose to $2.7 million, and procedure instrument revenue hit $4.8 million. Despite a slight dip in gross margin to 24% due to supply chain issues, operational efficiency is improving. The company launched the CleanFlow Technology in April 2022 and has an install base of approximately 900 units. Sonendo anticipates full-year revenue between $40.5 million and $42.5 million, indicating 22% to 28% annual growth.
Sonendo, a leading dental technology company, will release its second quarter 2022 financial results on August 10, 2022, after market close. A conference call is scheduled for 1:30 PM PT / 4:30 PM ET to discuss the results. Investors can access the call by dialing (844) 200-6205 domestically or (929) 526-1599 internationally, using access code: 283383. The company is known for its GentleWave® System, which innovatively treats tooth decay and enhances dental practice workflows.
Sonendo (NYSE: SONX) has appointed Joanne Lindberg as Vice President of Sales for North America to accelerate sales growth for its GentleWave® System. With over 20 years of experience in the technology and medical device sectors, Lindberg's leadership aims to increase market penetration in the U.S. and Canada. She has a proven track record in high-performing teams and strategic sales execution. CEO Michael Smith expressed confidence in Lindberg's ability to drive the company’s commercial strategy. The GentleWave System addresses over 17 million root canal procedures annually, presenting significant growth opportunities.
Sonendo, Inc. (NYSE: SONX) announced the upcoming departures of Jacqueline Collins, General Counsel, and Mehrzad Khakpour, Chief Technology Officer, both effective July 2022. Collins played a key role in developing the legal framework that facilitated the company's IPO in 2021, while Khakpour contributed to its early research and technology initiatives. The company is currently seeking new leaders to guide its R&D efforts. Despite these changes, Sonendo continues to grow, with over 800,000 GentleWave procedures performed, showcasing the technology's adoption.
On May 24, 2022, Sonendo (NYSE: SONX) appointed Crowe PR as its agency of record to enhance brand visibility through a multi-channel communications program. Crowe PR will support Sonendo's strategic communications for its GentleWave® System, which offers a less invasive alternative to traditional root canal therapy. Since its public debut in October 2021, Sonendo has performed over 800,000 GentleWave procedures, reflecting its growth in the dental technology sector. Executives emphasize a goal to increase awareness among endodontists and consumers.
Sonendo, Inc. (NYSE: SONX), a leader in dental technology, will participate in the Stifel Jaws and Paws Conference on June 1 at 8:35 a.m. ET. President & CEO Bjarne Bergheim and CFO Michael Watts will present during the event. The presentation will be accessible via an audio webcast on the company’s website at www.sonendo.com.
Sonendo develops the GentleWave® System, which revolutionizes root canal therapy by cleaning and disinfecting teeth without invasive procedures, leading to improved clinical outcomes and economics for dental practices.
Sonendo reported a 22% increase in total revenue for Q1 2022, reaching $9.0 million, driven by higher GentleWave console and procedure instrument sales.
Gross margin improved to 25% from 23% year-over-year, despite supply chain disruptions. However, operating expenses grew significantly, leading to a net loss of $15.5 million, up from $10.9 million in Q1 2021. The company maintains its full-year revenue guidance of $40 million to $43 million.
Sonendo (NYSE: SONX) is participating in the American Association of Endodontists’ Annual Meeting from April 27-30, 2022, in Phoenix, AZ. The event marks the first in-person meeting since 2019, expecting over 3,000 industry professionals. Sonendo will showcase its new CleanFlow procedure instrument designed for a less invasive root canal experience. Attendees can engage in hands-on demonstrations of the GentleWave System and attend lectures from key opinion leaders. Sonendo aims to enhance adoption of its technology and network with peers.
Sonendo, Inc. (NYSE: SONX) has launched the CleanFlow™ procedure instrument for its GentleWave® System, aimed at enhancing root canal therapy. This new technology simplifies workflow, minimizes steps for practitioners, and significantly improves patient experience, with 99.5% of patients reporting no pain during the procedure. With over 800,000 GentleWave procedures completed, Sonendo demonstrates strong market adoption and commitment to innovation in dental technology.
FAQ
What is the current stock price of SONENDO (SONX)?
What is the market cap of SONENDO (SONX)?
What is Sonendo, Inc. known for?
What technology does the GentleWave® System use?
How does the GentleWave® System benefit patients?
Who are some of Sonendo's investors?
Is Sonendo a publicly traded company?
What is multisonic ultracleaning™ technology?
What makes the GentleWave® System unique?
How does Sonendo support dental practitioners?
What impact does Sonendo aim to have on dental care?
Where can I find the latest news about Sonendo?
